Fundraising Fox

Krystalbio

Pittsburgh, US · Founded 2017 · 3 known investors

krystalbio.com ↗

Krystal Biotech develops and commercializes redosable gene therapies to treat severe, rare, and life-threatening diseases with limited or no approved treatments. Its first commercial product, VYJUVEK, is a redosable gene therapy for dystrophic epidermolysis bullosa.

BiotechMedical Devicesin /krystal-biotech-inc@KrystalBiotech

Founders & leadership

DN
Doug NorbyDirector
DR
Dino RossiDirector
SM
Suma M. KrishnanDirector
KS
Krish S. KrishnanExecutive Officer, Director
DJ
Dan JanneyDirector

Investors · 3

Avoro Capital AdvisorsNew York
Frazier Life SciencesPalo Alto
Alta PartnersreportedJackson · $1M – $12Mvia Dan Janney · board

Reported raises · per SEC filings

Form D private placements
▶$11.3MraisedAug 2017 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Doug NorbyDirector
  • Dan JanneyDirector
  • Dino RossiDirector
  • Suma M. KrishnanDirector
  • Krish S. KrishnanExecutive Officer, Director
Offering amount
$11.3M
Amount sold
$11.3M
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.